Effects of huperzine A on nucleus basalis magnocellularis lesion- induced spatial working memory deficit

Acta Pharmacologica Sinica

Volumn 19, Issue 2, 1998, Pages 128-132

  Xiong, Zhi Qi ^a   Cheng, Dong Hang ^a   Tang, Xi Can ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Choline acteyltransferase; Cholinesterase inhibitors; Huperzine A; Kainic acid; Learning; Maze; Memory; Physostigmine; Substantia innominata

Indexed keywords

ACETYLCHOLINESTERASE; HUPERZINE A; PHYSOSTIGMINE;

AMNESIA; ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; ENZYME ACTIVITY; MAGNOCELLULAR NUCLEUS; MAZE TEST; NONHUMAN; OLIVARY NUCLEUS; RAT; SPATIAL MEMORY; TASK PERFORMANCE;

ANIMALS; CEREBRAL CORTEX; CHOLINE O-ACETYLTRANSFERASE; CHOLINESTERASE INHIBITORS; KAINIC ACID; MALE; MAZE LEARNING; PHYSOSTIGMINE; RATS; RATS, SPRAGUE-DAWLEY; RETENTION (PSYCHOLOGY); SESQUITERPENES; SUBSTANTIA INNOMINATA;

EID: 0142000031     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bartus RT, Dean RL III, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1962; 217: 408-17.
2. Coyle JT, Price DL, DeLong MR. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983; 219: 1184-90.
3. Pendlebury WW, Solomon PR. Alzheimer's disease: therapeutic strategies for the 1990s. Neurobiol Aging 1994; 15: 287-9.
4. Watkins PB, Zimmerman HJ, Knapp MJ, Gracon SI, Lewis KW. Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. J Am Med Assoc 1991; 271: 992-8.
5. Liu JS, Zhu YL, Yu CM, Zhou YZ, Han YY, Wu FW, et al. The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity. Can J Chem 1986; 64: 837-9.
6. Wang YE, Yue DX, Tang XC. Anti-cholinesterase activity of huperzine A. Acta Pharmacol Sin 1986; 7: 110-3.
7. Yan XF, Lu WH, Lou WJ, Tang XC. Effects of huperzine A and B on skeletal muscle and electroencephalogram. Acta Pharmacol Sin 1967; 8: 117-23.
8. Tang XC, Xiong ZQ, Qian BC, Zhou ZF, Zhang CL. Cognition improvement by oral huperzine A: a novel acetylcholinesterase inhibitor. In: Giacobini E, Becker R, editors. Alzheimer disease: therapeutic strategies. Boston: Birkhäuser; 1994. p 113-9.
9. Xiong ZQ, Tang XC. Effect of huperzine A, a novel acetylcholinesterase inhibitor, on radial maze performance in rats. Pharmacol Biochem Behav 1995; 51: 415-9.
10. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. New York: Academic Press; 1982.
11. Chrobak JJ, Hanin I, Schmechel DE, Walsh TJ. AF64A-induced working memory impairment: behavioral, neurochemical and histological correlates. Brain Res 1988; 463: 107-17.
12. Leventer S, McKeag D, Clancy M, Wulfert E, Hanin I. Intracerebroventricular administration of ethylcholine mustard aziridinium ion (AF64A) reduces release of acetylcholine from rat hippocampal slices. Neuropharmacology 1985; 24: 453-9.
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
14. Archer T, Fowler CJ. Towards an animal model for the cholinergic lesion in Alzheimer's disease. Trends Pharmacol Sci 1985; 6: 61.
15. Smith G. Animal models of Alzheimer's disease: experimental cholinergic denervation. Brain Res Rev 1988; 13: 103-18.